Skip Navigation

Nephrology Dialysis Transplantation 2005 20(4):691; doi:10.1093/ndt/gfh715
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Couser, W.
Right arrow Articles by Morris, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Couser, W.
Right arrow Articles by Morris, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Special Feature

Trial registry policy: common editorial statement A uniform clinical trial registration policy for journals of kidney diseases, dialysis and transplantation

William Couser, MD

Journal of the American Society of Nephrology

Tilman Drüeke, MD

Nephrology Dialysis Transplantation

Phillip Halloran, MD

The American Journal of Transplantation

Bertram Kasiske, MD

The American Journal of Kidney Diseases

Saulo Klahr, MD

Kidney International

Peter Morris, MD

Transplantation

Medical research can be seriously compromised by the selective publication of clinical trial results. Therefore, it is imperative that information regarding clinical trials should be available to the general public.

We require, as a condition of consideration for publication, registration in a public trials registry. Trials must register at or before the onset of patient enrolment. This policy applies to any clinical trial starting enrolment after 1 January 2006. For trials that began enrolment before this date, we require registration by 1 April 2006 before considering the trial for publication.

We define a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g. phase 1 trials) are exempt.

We do not advocate one particular registry, but registration must be with a registry that meets the following minimum criteria:

  1. Accessible to the public at no charge.
  2. Searchable by standard, electronic (Internet-based) methods.
  3. Open to all prospective registrants free of charge or at minimal cost.
  4. Validates registered information.
  5. Identifies trials with a unique number.
  6. Includes information on the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing or closed) and funding source(s).

Registries that currently meet these criteria include:

  1. The registry sponsored by the US National Library of Medicine (www.clinicaltrials.gov).
  2. The International Standard Randomised Controlled Trial Number registry (www.contolled-trials.com).
  3. The Cochrane Renal Group registry (www.cochrane-renal.org/trialsubmissionform.php).
  4. The National (UK) Research Register (www.update-software.com/national/).
  5. European Clinical Trials Database (http://eudract.emea.eu.int/).

        13 January 2005


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
A. Mondry, M. Loh, K. B. Laurence, and N. Low
DNA polymorphisms and renal disease: a critical appraisal of studies presented at the annual ERA/EDTA and ASN conferences in 2004 and 2005
Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2775 - 2779.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Couser, W.
Right arrow Articles by Morris, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Couser, W.
Right arrow Articles by Morris, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?